FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing HIV protease inhibitor atazanavir sulphate in form of Form A crystals, which involves reacting a solution of a free base of atazanavir in an organic solvent in which atazanavir sulphate is virtually insoluble, at temperature ranging from 35°C to 55°C with a first portion of concentrated sulphuric acid in an amount sufficient for reaction with less than approximately 15 wt % free base of atazanavir, addition of nucleating centres of Form A atazanavir sulphate crystals, addition of an additional amount of concentrated sulphuric acid in several steps, where the acid is added at increasing rate to form atazanavir sulphate crystals and drying the atazanavir sulphate to form Form A crystals. A method of producing atazanavir sulphate in form of Form C crystals is also proposed.
EFFECT: improved method.
20 cl, 11 dwg, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW POLYMORPHIC FORM OF A CALCIEMETRIC COMPOUND | 2011 |
|
RU2599789C2 |
| NEW CRYSTALLINE FORMS | 2007 |
|
RU2446156C2 |
| NEW CRYSTALLINE FORMS OF TIOTROPIUM BROMIDE | 2006 |
|
RU2417224C2 |
| PHARMACEUTICAL COMPOSITION WITH TELMISARTAN SODIUM SALT | 2004 |
|
RU2372918C2 |
| METHOD FOR OBTAINING A DERIVATIVE OF 7H-PYRROLO[2,3-D] PYRIMIDINE AND ITS INTERMEDIATE | 2016 |
|
RU2755618C2 |
| CRYSTALLINE FORM OF INHIBITOR BISULPHATE JAK AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2704795C2 |
| SOLID FORMS OF CEFTOLOZANE | 2014 |
|
RU2703457C2 |
| 3-[2-(DIMETHYLAMINO)METHYL-(CYCLOHEX-1-YL)]PHENOL MALEATE AND ITS CRYSTALLINE FORMS | 2006 |
|
RU2434845C2 |
| 2-[4-(METHYLAMINOMETHYL)PHENYL]-5-FLUORO-BENZOFURAN-7-CARBOXAMIDE HYDROCHLORIDE POLYMORPHOUS, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2783418C1 |
| METHOD FOR PREPARING 2-HYDROXY-4-METHYLTHIO- BUTANOIC ACID | 2000 |
|
RU2213729C2 |
